Target
Alpha-2A adrenergic receptor
Ligand
BDBM50474630
Substrate
n/a
Meas. Tech.
ChEMBL_33207 (CHEMBL643232)
Ki
45±n/a nM
Citation
 Altenbach, RJKhilevich, AKolasa, TRohde, JJBhatia, PAPatel, MVSearle, XBYang, FBunnelle, WHTietje, KBayburt, EKCarroll, WAMeyer, MDHenry, RBuckner, SAKuk, JDaza, AVMilicic, IVCain, JCKang, CHIreland, LMCarr, TLMiller, TRHancock, AANakane, MEsbenshade, TABrune, MEO'Neill, ABGauvin, DMKatwala, SPHolladay, MWBrioni, JDSullivan, JP Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist. J Med Chem 47:3220-35 (2004) [PubMed]  Article 
Target
Name:
Alpha-2A adrenergic receptor
Synonyms:
ADA2A_HUMAN | ADRA2A | ADRA2R | ADRAR | Adrenergic alpha2A | Adrenergic receptor alpha | Alpha-2 adrenergic receptor subtype C10 | Alpha-2A adrenoceptor | Alpha-2A adrenoreceptor | Alpha-2AAR | alpha-2A adrenergic receptor [Homo sapiens]
Type:
Enzyme
Mol. Mass.:
48979.91
Organism:
Homo sapiens (Human)
Description:
P08913
Residue:
465
Sequence:
MFRQEQPLAEGSFAPMGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIITVWVISAVISFPPLISIEKKGGGGGPQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDAVAAPPGGTERRPNGLGPERSAGPGGAEAEPLPTQLNGAPGEPAPAGPRDTDALDLEESSSSDHAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGATGIGTPAAGPGEERVGAAKASRWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSSLNPVIYTIFNHDFRRAFKKILCRGDRKRIV
  
Inhibitor
Name:
BDBM50474630
Synonyms:
CHEMBL108804
Type:
Small organic molecule
Emp. Form.:
C14H17N3O3S
Mol. Mass.:
307.368
SMILES:
CS(=O)(=O)Nc1c(O)ccc2C(CCCc12)c1c[nH]cn1
Structure:
Search PDB for entries with ligand similarity: